Real-time enrollment status for this autoimmune disease clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:33 AM UTC
| NCT Number | NCT06293365 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Autoimmune Disease |
| Phase | Clinical Trial |
| Target Enrollment | 140 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | December 4, 2025 (Dec 4, 2025) |
As of March 2, 2026: Clinical trial NCT06293365 is currently active_not_recruiting participants. This clinical trial study for autoimmune disease is not currently accepting new participants at 17 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06293365 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06293365 was last updated Dec 4, 2025 (December 4, 2025). HelloStudys verifies this status automatically.